We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Polarean Imaging Plc | LSE:POLX | London | Ordinary Share | GB00BF3DT583 | ORD GBP0.00037 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 2.04% | 1.25 | 1.20 | 1.30 | 1.275 | 1.20 | 1.23 | 4,330,953 | 16:19:17 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 1.03M | -13.91M | -0.0644 | -0.19 | 2.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/5/2024 21:08 | With the FDA approval now in hand, the company intends to focus its commercialisation efforts towards the top 1,000 or so US academic and teaching hospitals providing respiratory medicine services. | pirates4 | |
10/5/2024 17:14 | If nothing else it’s given a few twitchy sellers a chance to bail out. | wetdream | |
10/5/2024 16:32 | Agreed bones. | nigelpm | |
10/5/2024 16:28 | And down it comes after all your pontificating. End of the day they need to raise money and turnover is so low they are a long way from breaking even. Watch when they announce the placing at 1-2p in a few weeks time imo | bones698 | |
10/5/2024 15:43 | So money is incoming from sales and a exhibition next week should kick up a notch. More intrest. | pirates4 | |
10/5/2024 15:40 | It's already FDA approved in the USA so the demand is there, also for patients with ling term covid breathing difficulties. | pirates4 | |
10/5/2024 15:33 | https://www.itnonlin | pirates4 | |
10/5/2024 15:27 | Revenues from new orders and completed sales in 2024 will now tally some US$2.5 million, Polaren CEO Christopher von Jako said, adding that the company is expecting further orders.https://www.p | pirates4 | |
10/5/2024 15:23 | Simply stating the facts - shame you aren't able to do that eh? | nigelpm | |
10/5/2024 14:59 | Buyers run in end of day bug jump on Monday say goodbye . | pirates4 | |
10/5/2024 14:58 | “both filtered suggest everyone else does the same.” Ummm. Errr. Didn’t we post the RNSs? Why not filter them aswell? | purchaseatthetop | |
10/5/2024 14:51 | Investors see an opportunity here stoll buying g in thousands | pirates4 | |
10/5/2024 14:43 | Wow uninvested ... pathetic twins at it.both filtered suggest everyone else does the same. 2 Fridays 2 new deals get Over it let the shareholders have their day . Leading to a sustained rise. | moontheloon | |
10/5/2024 14:07 | As usual. We agree. Respect. | purchaseatthetop | |
10/5/2024 13:54 | That's the point I'm making PATT. Exactly that - they cannot get close to running out of cash. My earlier appears to have been very prophetic - don't buy the spike! | nigelpm | |
10/5/2024 13:39 | Nigelpm. Fair point but they simply cannot run out of cash. Even if it is Oct 24 that is so close and they must be dealing with it now. Trading won’t create the cash and today’s sale is “expected 2024”. It may hurt holders short term and my point is not that the company cannot thrive. It is simply that now may not be the time to buy. Good luck all holders. | purchaseatthetop | |
10/5/2024 13:33 | It certainly won't be pretty though for equity. I would think the strategy is land as many deals as possible (who knows at what price given lack of any detail in RNS) before fundraising in an attempt to get as much as possible. | nigelpm | |
10/5/2024 13:33 | They must have a reasonable chance of landing the funding otherwise they'd already be approaching requirement to disclose insolvent trading. | nigelpm | |
10/5/2024 13:32 | Yes - I get all that. You are wrong though on timing - per recent RNS - In August 2023, the Company implemented strict cost control measures. These measures resulted in a cash balance of $6.1m on 31 December 2023 (unaudited), extending the cash runway into October 2024 (previously June 2024). | nigelpm | |
10/5/2024 13:29 | Nigel. The final accounts to 31/12/23 will be with the auditors and NOMAD right now. They have to 30/6/24 to release accounts. They have to show 12 months cash runway to avoid going concern qualification so will be raising now to get that signed off. It was the word “expected̶ They must raise cash I think we all agree. Moontheloon seems to think not. He or she is fully entitled to that view. Buti have not been wrong on POLX so far… | purchaseatthetop | |
10/5/2024 13:23 | PATT - I can't imagine they are trading insolvently so would think they'd had the nod on funding but it won't be at a premium to existing share price! | nigelpm | |
10/5/2024 13:12 | Look. I love the tech and think it could be great but don’t buy until after the cash raise and only then if they actually might start generating $1m a month in revenue gross margin to cover their costs. They don’t even have pharmacy benefit managers in place. Their customers cannot earn commercial revenue from medical insurance. That is why sales are only done to research hospitals. | purchaseatthetop | |
10/5/2024 13:04 | Advfn financial looking good for polx | pirates4 | |
10/5/2024 12:55 | That’s right Moontheloon. Let’s ignore what the company itself told us all…… | purchaseatthetop | |
10/5/2024 12:52 | The product is moving in the right direction | pirates4 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions